Top-News

3d Signatures News

Keine aktuellen Kursdaten verfügbar
WKN: A2AUDV
ISIN: CA88555C1077
Typ: Aktie

3d Signatures News

03.04.18 - GlobeNewswire
3D Signatures Inc. Announces Successful Scoring Model Development and Analytical Validation of the Telo-HL(TM) Test for Hodgkin's Lymphoma
3D Signatures Inc. Announces Successful Scoring Model Development and Analytical Validation of the Telo-HL(TM) Test for Hodgkin's Lymphoma 3D Signatures Inc. / 3D ...
28.03.18 - GlobeNewswire
3D Signatures Collaborates with MDxHealth to Evaluate Telo-PC(TM) Test in Prostate Cancer
3D Signatures Collaborates with MDxHealth to Evaluate Telo-PC(TM) Test in Prostate Cancer 3D Signatures Inc. / 3D Signatures Collaborates with MDxHealth to Evaluate Telo-...
06.03.18 - GlobeNewswire
3D Signatures Inc. and l'Institut Universitaire de Cardiologie et de Pneumologie de Québec (IUCPQ) Announce Collaboration to Combine TeloView(TM) with Genome Sequence Analysis in Lung Cancer
3D Signatures Inc. and l'Institut Universitaire de Cardiologie et de Pneumologie de Québec (IUCPQ) Announce Collaboration to Combine TeloView(TM) with Genome Sequence ...
22.02.18 - GlobeNewswire
3D Signatures Inc. gibt positive Topline-Ergebnisse der Entwicklungsstudie zur Beurteilung seines Telo-HL(TM)-Tests für das Hodgkin-Lymphom bekannt
3D Signatures Inc. gibt positive Topline-​Ergebnisse der Entwicklungsstudie zur Beurteilung seines Telo-HL(TM)-Tests für das Hodgkin-​Lymphom bekannt 3D Signatures Inc. / 3D ...
20.02.18 - GlobeNewswire
3D Signatures Inc. Announces Positive Topline Results of Development Trial Assessing its Telo-HL(TM) Test for Hodgkin's Lymphoma
3D Signatures Inc. Announces Positive Topline Results of Development Trial Assessing its Telo-HL(TM) Test for Hodgkin's Lymphoma 3D Signatures Inc. / 3D Signatures Inc. ...

Newssuche

Videos

newspaper
08:40 Uhr +2,33%
Technical Trading: Gold Long freitags
Gold Long Typ: Turbo Open End WKN: NG8DB8 Hebel: 27 Laufzeit: OpenEnd Einstieg: Market ... Mehr »